Skip to main content

WNK kinases and blood pressure control

Abstract

The WNK (With No K-Lysine) family of proteins is widely expressed and has been shown to promote blood pressure homeostasis through a variety of mechanisms. Members of this family have been reported to affect sodium/chloride cotransporters, sodium/potassium/chloride cotransporters, potassium/chloride cotransporters, the renal outer medullary potassium channel, and the epithelial sodium channel, directly and indirectly. Mutations in WNK1 and WNK4 were shown to cause pseudohypoaldosteronism type II, a Mendelian disorder characterized by hypertension, hyperkalemia, and acidosis. Because of the complexity of the renal system, it has been difficult to completely define the role of these kinases in kidney function. This article reviews current knowledge of the role of these proteins in ion homeostasis and volume control.

This is a preview of subscription content, access via your institution.

References and Recommended Reading

  1. O’shaughnessy KM, Karet FE: Salt handling and hypertension. Annu Rev Nutr 2006, 26:343–365.

    Article  PubMed  CAS  Google Scholar 

  2. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001, 104:545–556.

    Article  CAS  PubMed  Google Scholar 

  3. Kahle KT, Ring AM, Lifton RP: Molecular physiology of the WNK kinases. Annu Rev Physiol 2008, 70:329–355.

    Article  CAS  PubMed  Google Scholar 

  4. Gamba G: WNK lies upstream of kinases involved in regulation of ion transporters. Biochem J 2005, 391:e1–e3.

    Article  CAS  PubMed  Google Scholar 

  5. Xu B, English JM, Wilsbacher JL, et al.: WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 2000, 275:16795–16801.

    Article  CAS  PubMed  Google Scholar 

  6. Min X, Lee BH, Cobb MH, Goldsmith EJ: Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure 2004, 12:1303–1311.

    Article  CAS  PubMed  Google Scholar 

  7. Lenertz LY, Lee BH, Min X, et al.: Properties of WNK1 and implications for other family members. J Biol Chem 2005, 280:26653–26658.

    Article  CAS  PubMed  Google Scholar 

  8. He G, Wang HR, Huang SK, Huang CL: Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 2007, 117:1078–1087.

    Article  CAS  PubMed  Google Scholar 

  9. Murakami-Kojima M, Nakamichi N, Yamashino T, Mizuno T: The APRR3 component of the clock-associated APRR1/TOC1 quintet is phosphorylated by a novel protein kinase belonging to the WNK family, the gene for which is also transcribed rhythmically in Arabidopsis thaliana. Plant Cell Physiol 2002, 43:675–683.

    Article  CAS  PubMed  Google Scholar 

  10. Ruiz-Perez VL, Murillo FJ, Torres-Martinez S: PkpA, a novel Phycomyces blakesleeanus serine/threonine protein kinase. Curr Genet 1995, 28:309–316.

    Article  CAS  PubMed  Google Scholar 

  11. Verissimo F, Jordan P: WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001, 20:5562–5569.

    Article  CAS  PubMed  Google Scholar 

  12. Xie J, Craig L, Cobb MH, Huang CL: Role of with-no-lysine [K] kinases in the pathogenesis of Gordon’s syndrome. Pediatr Nephrol 2006, 21:1231–1236.

    Article  PubMed  Google Scholar 

  13. Boutros M, Kiger AA, Armknecht S, et al.: Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 2004, 303:832–835.

    Article  CAS  PubMed  Google Scholar 

  14. Hong C, Moorefield KS, Jun P, et al.: Epigenome scans and cancer genome sequencing converge on WNK2, a kinaseindependent suppressor of cell growth. Proc Natl Acad Sci U S A 2007, 104:10974–10979.

    Article  CAS  PubMed  Google Scholar 

  15. Sun X, Gao L, Yu RK, Zeng G: Down-regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration. J Neurochem 2006, 99:1114–1121.

    Article  CAS  PubMed  Google Scholar 

  16. Zambrowicz BP, Abuin A, Ramirez-Solis R, et al.: Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci U S A 2003, 100:14109–14114.

    Article  PubMed  Google Scholar 

  17. Fu Y, Subramanya A, Rozansky D, Cohen DM: WNK kinases influence TRPV4 channel function and localization. Am J Physiol 2006, 290:F1305–F1314.

    CAS  Article  Google Scholar 

  18. Lee BH, Chen W, Stippec S, Cobb MH: Biological cross-talk between WNK1 and the transforming growth factor beta-Smad signaling pathway. J Biol Chem 2007, 282:17985–17996.

    Article  CAS  PubMed  Google Scholar 

  19. Oh E, Heise CJ, English JM, et al.: WNK1 is a novel regulator of Munc18c-syntaxin 4 complex formation in soluble NSF attachment protein receptor (SNARE)-mediated vesicle exocytosis. J Biol Chem 2007, 282:32613–32622.

    Article  CAS  PubMed  Google Scholar 

  20. Wilson FH, Disse-Nicodeme S, Choate KA, et al.: Human hypertension caused by mutations in WNK kinases. Science 2001, 293:1107–1112.

    Article  CAS  PubMed  Google Scholar 

  21. Delaloy C, Lu J, Houot AM, et al.: Multiple promoters in the WNK1 gene: one controls expression of a kidneyspecific kinase-defective isoform. Mol Cell Biol 2003, 23:9208–9221.

    Article  CAS  PubMed  Google Scholar 

  22. O’Reilly M, Marshall E, Macgillivray T, et al.: Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006, 17:2402–2413.

    Article  PubMed  CAS  Google Scholar 

  23. Kahle KT, Gimenez I, Hassan H, et al.: WNK4 regulates apical and basolateral Cl- flux in extrarenal epithelia. Proc Natl Acad Sci U S A 2004, 101:2064–2069.

    Article  CAS  PubMed  Google Scholar 

  24. Choate KA, Kahle KT, Wilson FH, et al.: WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl- -transporting epithelia. Proc Natl Acad Sci U S A 2003, 100:663–668.

    Article  CAS  PubMed  Google Scholar 

  25. Holden S, Cox J, Raymond FL: Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). Gene 2004, 335:109–119.

    Article  CAS  PubMed  Google Scholar 

  26. Kahle KT, Rinehart J, de Los Heros P, et al.: WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability. Proc Natl Acad Sci U S A 2005, 102:16783–16788.

    Article  CAS  PubMed  Google Scholar 

  27. San-Cristobal P, de los Heros P, Ponce-Coria J, et al.: WNK kinases, renal ion transport and hypertension. Am J Nephrol 2008, 28:860–870.

    Article  CAS  PubMed  Google Scholar 

  28. Wilson FH, Kahle KT, Sabath E, et al.: Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003, 100:680–684.

    Article  CAS  PubMed  Google Scholar 

  29. Yang CL, Angell J, Mitchell R, Ellison DH: WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003, 111:1039–1045.

    CAS  PubMed  Google Scholar 

  30. Cai H, Cebotaru V, Wang YH, et al.: WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells. Kidney Int 2006, 69:2162–2170.

    Article  CAS  PubMed  Google Scholar 

  31. Subramanya AR, Liu J, Ellison DH, et al.: WNK4 diverts the thiazide-sensitive NaCl cotransporter to the lysosome and stimulates AP-3 interaction. J Biol Chem 2009, 284:18471–18480.

    Article  CAS  PubMed  Google Scholar 

  32. Yang CL, Zhu X, Wang Z, et al.: Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 2005, 115:1379–1387.

    CAS  PubMed  Google Scholar 

  33. Lazrak A, Liu Z, Huang CL: Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A 2006, 103:1615–1620.

    Article  CAS  PubMed  Google Scholar 

  34. Wade JB, Fang L, Liu J, et al.: WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci U S A 2006, 103:8558–8563.

    Article  CAS  PubMed  Google Scholar 

  35. Yang CL, Zhu X, Ellison DH: The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007, 117:3403–3411.

    Article  CAS  PubMed  Google Scholar 

  36. de Los Heros P, Kahle KT, Rinehart J, et al.: WNK3 bypasses the tonicity requirement for K-Cl cotransporter activation via a phosphatase-dependent pathway. Proc Natl Acad Sci U S A 2006, 103:1976–1981.

    Article  PubMed  CAS  Google Scholar 

  37. Anselmo AN, Earnest S, Chen W, et al.: WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells. Proc Natl Acad Sci U S A 2006, 103:10883–10888.

    Article  CAS  PubMed  Google Scholar 

  38. Gagnon KB, England R, Delpire E: Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol Cell Biol 2006, 26:689–698.

    Article  CAS  PubMed  Google Scholar 

  39. Piechotta K, Lu J, Delpire E: Cation chloride cotransporters interact with the stress-related kinases Ste20-related prolinealanine- rich kinase (SPAK) and oxidative stress response 1 (OSR1). J Biol Chem 2002, 277:50812–50819.

    Article  CAS  PubMed  Google Scholar 

  40. Richardson C, Rafiqi FH, Karlsson HK, et al.: Activation of the thiazide-sensitive Na + -Cl cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci 2008, 121:675–684.

    Article  CAS  PubMed  Google Scholar 

  41. Vitari AC, Deak M, Morrice NA, Alessi DR: The WNK1 and WNK4 protein kinases that are mutated in Gordon’s hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 2005, 391:17–24.

    Article  CAS  PubMed  Google Scholar 

  42. Dowd BF, Forbush B: PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1). J Biol Chem 2003, 278:27347–27353.

    Article  CAS  PubMed  Google Scholar 

  43. Ponce-Coria J, San-Cristobal P, Kahle KT, et al.: Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci U S A 2008, 105:8458–8463.

    Article  CAS  PubMed  Google Scholar 

  44. Cope G, Murthy M, Golbang AP, et al.: WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. J Am Soc Nephrol 2006, 17:1867–1874.

    Article  CAS  PubMed  Google Scholar 

  45. Kahle KT, Wilson FH, Leng Q, et al.: WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 2003, 35:372–376.

    Article  CAS  PubMed  Google Scholar 

  46. Leng Q, Kahle KT, Rinehart J, et al.: WNK3, a kinase related to genes mutated in hereditary hypertension with hyperkalaemia, regulates the K+ channel ROMK1 (Kir1.1). J Physiol 2006, 571:275–286.

    CAS  PubMed  Google Scholar 

  47. Wang HR, Liu Z, Huang CL: Domains of WNK1 kinase in the regulation of ROMK1. Am J Physiology 2008, 295:F438–F445.

    CAS  Google Scholar 

  48. Ring AM, Cheng SX, Leng Q, et al.: WNK4 regulates activity of the epithelial Na + channel in vitro and in vivo. Proc Natl Acad Sci U S A 2007, 104:4020–4024.

    Article  CAS  PubMed  Google Scholar 

  49. Xu BE, Stippec S, Lazrak A, et al.: WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and noncatalytic mechanism. J Biol Chem 2005, 280:34218–34223.

    Article  CAS  PubMed  Google Scholar 

  50. Debonneville C, Flores SY, Kamynina E, et al.: Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression. EMBO J 2001, 20:7052–7059.

    Article  CAS  PubMed  Google Scholar 

  51. Kahle KT, Macgregor GG, Wilson FH, et al.: Paracellular Cl- permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension. Proc Natl Acad Sci U S A 2004, 101:14877–14882.

    Article  CAS  PubMed  Google Scholar 

  52. Yamauchi K, Rai T, Kobayashi K, et al.: Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A 2004, 101:4690–4694.

    Article  CAS  PubMed  Google Scholar 

  53. Liu Z, Wang HR, Huang CL: Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. J Biol Chem 2009, 284:12198–12206.

    Article  CAS  PubMed  Google Scholar 

  54. Lalioti MD, Zhang J, Volkman HM, et al.: Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006, 38:1124–1132.

    Article  CAS  PubMed  Google Scholar 

  55. Yang SS, Morimoto T, Rai T, et al.: Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 2007, 5:331–344.

    Article  CAS  PubMed  Google Scholar 

  56. San-Cristobal P, Pacheco-Alvarez D, Richardson C, et al.: Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci U S A 2009, 106:4384–4389.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Melanie H. Cobb.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Deaton, S.L., Sengupta, S. & Cobb, M.H. WNK kinases and blood pressure control. Current Science Inc 11, 421–426 (2009). https://doi.org/10.1007/s11906-009-0072-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-009-0072-z

Keywords

  • Distal Convoluted Tubule
  • Distal Nephron
  • Epithelial Sodium Channel
  • Pseudohypoaldosteronism Type
  • Lower Serum Potassium Level